PartnersLogo Cohorte EGEA

The EGEA team has developed many scientific partnerships for the analyses
and valorisation of the large amount of data collected from this research infrastructure.
The research team is currently collaborating with:

The 5 hospital university partners of the new EGEA follow-up (EGEA4)

The 5 hospital university partners of the new EGEA follow-up (EGEA4)

who will be in charge of performing the examinations of EGEA4 participants from 2023 onwards. The Biological Resource Center of the Grenoble Alpes University Hospital will be in charge of storing all the biological samples of the EGEA4 follow-up.

Biological Resource Center in Lille and Dijon, France

Biological Resource Center in Lille and Dijon, France

who are storing the biological samples collected at EGEA1 and EGEA2.

IsGLOBAL, Barcelona, Spain

IsGLOBAL, Barcelona, Spain

IsGlobal is a large health research centre located in Barcelona (Spain). The scientific team of the EGEA cohort has been collaborating for many years with the environmental and respiratory epidemiology teams of this international research centre.

Department of Biosystems Science and Engineering, ETH Zurich, Bâle, Switzland

Department of Biosystems Science and Engineering, ETH Zurich, Bâle, Switzland

contributes to gene network analyses of asthma omics and associated phenotypes (MLFPM Consortium: https://mlfpm.eu/).

Inserm Team UMR-996

Inserm Team UMR-996

performed bioassays (assessment of exposure to quaternary ammonium salts).

The German Cebter for Lung Research at Children Hospital in Munich, Germany

The German Cebter for Lung Research at Children Hospital in Munich, Germany

participates in the research of genetic factors involved in the development of asthma and allergic diseases.

National Heart and Lung Institute,Imperial Collège of London, UK

National Heart and Lung Institute,Imperial Collège of London, UK

participates in the research of genetic factors involved in the development of asthma and allergic diseases.

Medical University of Vienna, Austria

Medical University of Vienna, Austria

The scientific team of the EGEA cohort has been collaborating for several years with the Department of Pathophysiology and Allergy Research of the University of Vienna, which has developed innovative techniques to measure antibodies (immune response) to allergens (Immunoglobulin E) and respiratory viruses (Immunoglobulin G).

University of Lille, Hospital University of Lille and Institut Pasteur Lille

University of Lille, Hospital University of Lille and Institut Pasteur Lille

The EGEA scientific team has a long-standing collaboration with the team "Impact of the chemical environment on health" (ULR4483, IMPECS) of the University of Lille for the development of biological assays. Many bioassays have been performed by this team.

Faculty of Medicine, University ofOulu, Oulu, Finland

Faculty of Medicine, University ofOulu, Oulu, Finland

with whom the EGEA scientific team collaborates on the impact of mould exposure on respiratory health.

Medicine University of Sichuan, Chengdu, Chine

Medicine University of Sichuan, Chengdu, Chine

participates in the development of nutrition projects.

Harvard Medical School, Department of Epidemiology

Harvard Medical School, Department of Epidemiology

participates in the development of projects on nutrition.

Quebec University, Chicoutimi, Department of fondamental sciences, Intersectoral Centre for Sustainable Health), Saguenay, Canada

Quebec University, Chicoutimi, Department of fondamental sciences, Intersectoral Centre for Sustainable Health), Saguenay, Canada

is involved in the research of genetic and epigenetic factors involved in the development of asthma and allergic diseases.

University of Bristol, Integrative Epidemiology Unit, UK

University of Bristol, Integrative Epidemiology Unit, UK

participates in the research of genetic factors involved in the development of asthma and allergic diseases.

University of Copenhaguen, Faculty of Health Sciences - Helev and Gentofte Hospital

University of Copenhaguen, Faculty of Health Sciences - Helev and Gentofte Hospital

participates in the research of genetic factors involved in the development of asthma and allergic diseases.

McGill University, McGill Genomic Center, Department of Human genetic, Montreal, Canada

McGill University, McGill Genomic Center, Department of Human genetic, Montreal, Canada

is involved in the research of genetic, epigenetic and metabolomic factors involved in the development of asthma and allergic diseases.

University of Missouri Kansas City, Genomic Medicine Center, Children's Mercy  Research Institute, Kansas City, United-States

University of Missouri Kansas City, Genomic Medicine Center, Children's Mercy  Research Institute, Kansas City, United-States

participates in the research of epigenetic factors of asthma and allergic diseases.

University of Kyoto, Genomic Medicine Center, École Supérieure de Médecine, Kyoto, Japon

University of Kyoto, Genomic Medicine Center, École Supérieure de Médecine, Kyoto, Japon

contributes to metabolomics studies for asthma and allergic diseases.

SLSJ, ALSPAC, GABRIELA, MRCA/MRCE, COPSAC

In the context of genetic and epigenetic studies, the team collaborates with the following studies/cohorts:

  • SLSJ (Saguenay-Lac-Saint-Jean),
  • ALSPAC (Avon Longitudinal Study of Parents and Children),
  • GABRIELA (GABRIEL Advanced surveys),
  • MRCA/MRCE (Medical Research Council asthma / eczema),
  • COPSAC (The Copenhagen Prospective Study on Asthma in Childhood).

University of Kyoto, Genomic Medicine Center, École Supérieure de Médecine, Kyoto, Japon

The EGEA scientific team has been collaborating for many years with the European cohort ECRHS (https://www.ecrhs.org) and more recently with the national cohorts Constances (https://www.constances.fr), and Nutrinet Santé (https://etude-nutrinet-sante.fr)

The scientific team of the EGEA cohort has collaborated in the past with:

  • Necker Hospital, Cochin Hospital and Trousseau Hospital Paris, which was in charge of the examinations of the participants for the Paris center in EGEA1 and EGEA2
  • Many international research teams in the context of the European Gabriel project (https://www.cnrgh.fr/gabriel/index.html), the international TAGC project on asthma genetics and the European ESCAPE project on air pollution (http://www.escapeproject.eu)
  • A group of international experts for the creation of the OAsJEM job-exposure matrix (ISGlobal, Barcelona, Spain; IRAS, Utrecht University, Utrecht, The Netherlands; Sahlgrenska University Hospital, Gothenburg, Sweden; Aarhus University, Copenhagen, Denmark; Monash University, Melbourne, Australia) and of national experts for the coding of jobs and re-evaluation of exposures (Industrial hygiene consulting, Courlaoux; Toxibio-consultant, Lescar; INRS, Nancy)
  • A group of national experts for the evaluation of occupational exposure to cleaning/disinfecting products (INRETS, Institut de Veille Sanitaire, Bron; Service Central de Médecine du Travail, APHP, Paris; Institut de Veille Sanitaire, Département Santé Travail (DST/InVS), Saint Maurice; Département Epidémiologie en Entreprise, INRS, Vandoeuvre-les-Nancy; Service de pathologie professionnelle, APHP Cochin)
  • Several cohorts: SAPALDIA (Switzerland), ECRHS (Europe), Hutterites (USA), Busselton (Australia), B58C (UK), UFA (Russia), TOMSK (Russia)
  • A research team from the National Institute of Public Health in Mexico City, Mexico, for projects on nutrition
  • The EFS in Annemasse, France, where the EGEA2 biological collection has been stored for many years
  • International teams in the framework of genetic programs:
    • Trans-National Asthma Genetic Consortium (TAGC)
    • EArly Genetics and Lifecourse Epidemiology (EAGLE) Consortium
    • National Heart & Lung Institute, Imperial College London, London, UK
    • ISGlobal, Barcelona, Spain
    • Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, University of Basel, Switzerland
    • Department of Human Genetics, University of Chicago, Chicago, USA
    • Department of Epidemiology, University of Groningen, Groningen, The Netherlands
    • Institute of Population Health Research, St George's University of London, London, UK
    • Department of Clinical Sciences and Education Södersjukhuset, Karolinska Institute, Stockholm, Sweden
    • Pediatric Allergy Clinic, Center for Experimental and Clinical Research, University Hospital Berlin Charité and Centre Max Delbrück, Berlin, Germany
    • Busselton Institute of Population Medicine, Sir Charles Gairdner Hospital, and the School of Population Health, University of Western Australia, Australia
    • Siberian State Medical University, Tomsk, Russia
    • Institute of Biochemistry and Genetics, Ufa Scientific Center, Russian Academy of Sciences, Ufa, Russia; Department of Genetics and Basic Medicine, Bashkir State University, Ufa, Russia